4.8 Editorial Material

Interleukin-35 takes the 'B' line

Journal

NATURE MEDICINE
Volume 20, Issue 6, Pages 580-581

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nm.3594

Keywords

-

Funding

  1. Versus Arthritis [17707, 19314] Funding Source: researchfish
  2. Arthritis Research UK [17707, 19314] Funding Source: Medline
  3. Versus Arthritis [17707, 19314] Funding Source: Medline

Ask authors/readers for more resources

Regulatory B cells exert an immunosuppressive role by secreting the cytokine interleukin-10 (IL-10). Two studies have now identified B cell derived IL-35 as both an inducer and a mediator of regulatory B cell function. IL-35 switched off inflammation in mouse models of autoimmunity, whereas its absence in B cells in mice enhanced survival after Salmonella enterica serovar Typhimurium infection. IL-35 could therefore be targeted for treating human autoimmune and infectious disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available